Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial). - Rauber C; Roberti MP; Vehreschild MJ; Tsakmaklis A; Springfeld C; Teufel A; Ettrich T; Jochheim L; Kandulski A; Missios P; Mohr R; Reichart A; et al. (BMJ open, 2025)